Silexion Therapeutics Corp (SLXN)
 NASDAQ: SLXN · Real-Time Price · USD
 3.300
 -0.140 (-4.07%)
  Oct 30, 2025, 4:00 PM EDT - Market closed
Silexion Therapeutics Employees
As of December 31, 2024, Silexion Therapeutics had 14 total employees, including 11 full-time and 3 part-time employees.
Employees 
 14
Change 
 n/a
Growth 
 n/a
Revenue / Employee 
 n/a
Profits / Employee 
 -$1,174,500
Market Cap 
1.85M
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 14 | - | - | 
Related Stocks
| Company Name | Employees | 
|---|---|
| UnitedHealth Group | 400,000 | 
| Johnson & Johnson | 138,100 | 
| Thermo Fisher Scientific | 125,000 | 
| Abbott Laboratories | 114,000 | 
| AstraZeneca | 92,900 | 
| Novo Nordisk | 77,349 | 
| Novartis AG | 75,883 | 
| Merck & Co. | 75,000 | 
SLXN News
- 4 weeks ago - Silexion Therapeutics Announces Positive New Human Cell Line Data Confirming Pan-KRAS Activity of SIL204, Demonstrating Up to 99.7% Inhibition and First Evidence in Gastric Cancer - GlobeNewsWire
- 5 weeks ago - Silexion Therapeutics Regains Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 7 weeks ago - Silexion Therapeutics Shares Surge On Positive Preclinical Pancreatic Cancer Data - Benzinga
- 7 weeks ago - Silexion Therapeutics Announces Pricing of $6.0 Million Public Offering - GlobeNewsWire
- 7 weeks ago - Silexion Therapeutics Reports Positive Preclinical Data Demonstrating SIL204's Reach and Activity in Major Pancreatic Cancer Metastatic Sites Following Systemic Administration - GlobeNewsWire
- 2 months ago - Silexion Therapeutics Announces Selection of Contract Research Organization to Support Upcoming Phase 2/3 Clinical Trials for SIL204 - GlobeNewsWire
- 2 months ago - Silexion Therapeutics to Present at the Upcoming 27th Annual H.C. Wainwright Global Investment Conference - GlobeNewsWire
- 2 months ago - Silexion Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire